New Zealand gives OK for diabetes xenotransplant trial
This article was originally published in Scrip
Executive Summary
The New Zealand health minister, Tony Ryall, has given the go-ahead for local biotech firm Living Cell Technologies to conduct a Phase I/IIa clinical trial of its Diabecell implant, which involves the transplantation of pig islet cells into insulin dependent diabetics.